Posted by ABMN Staff on May 7th, 2024
StockNews.com cut shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a report published on Monday morning.
Separately, Cantor Fitzgerald reaffirmed an overweight rating and issued a $12.00 price...
More of this article »